ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AztraZeneca to launch oncology drug Calquence in India expresspharma
October 19, 2020AstraZeneca Pharma India has received import and market permission in Form CT-20 (Marketing Authorization- Additional Indication) from the Drugs Controller General of India for Acalabrutinib 100 mg capsules (Calquence ).
Pharma Sources Insight January 2025
